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Abstract
Background: Toll like receptors (TLRs) signaling pathways, including the adaptor protein Mal encoded by the
TIRAP gene, play a central role in the development of acute lung injury (ALI). Recently, the TIRAP variants have
been described association with susceptibility to inflammatory diseases. The aim of this study was to investigate
whether genetic variants in TIRAP are associated with the development of ALI.
Methods: A case-control collection from Han Chinese of 298 healthy subjects, 278 sepsis-associated ALI and 288
sepsis alone patients were included. Three tag single nucleotide polymorphisms (SNPs) of the TIRAP gene and two
additional SNPs that have previously showed association with susceptibility to other inflammatory diseases were
genotyped by direct sequencing. The differences of allele, genotype and haplotype frequencies were evaluated
between three groups.
Results: The minor allele frequencies of both rs595209 and rs8177375 were significantly increased in ALI patients
compared with both healthy subjects (odds ratio (OR) = 1.47, 95% confidence interval (CI):1.15-1.88, P = 0.0027 and
OR = 1.97, 95% CI: (1.38-2.80), P = 0.0001, respectively) and sepsis alone patients (OR = 1.44, 95% CI: 1.12-1.85, P =
0.0041 and OR = 1.82, 95% CI: 1.28-2.57, P = 0.00079, respectively). Haplotype consisting of these two associated
SNPs strengthened the association with ALI susceptibility. The frequency of haplotype AG (rs595209A, rs8177375G)
in the ALI samples was significantly higher than that in the healthy control group (OR = 2.13, 95% CI: 1.46-3.09, P =
0.00006) and the sepsis alone group (OR = 2.24, 95% CI: 1.52-3.29, P = 0.00003). Carriers of the haplotype CA
(rs595209C, rs8177375A) had a lower risk for ALI compared with healthy control group (OR = 0.69, 95% CI:
0.54-0.88, P = 0.0003) and sepsis alone group (OR = 0.71, 95% CI: 0.55-0.91, P = 0.0006). These associations
remained significant after adjustment for covariates in multiple logistic regression analysis and for multiple
comparisons.
Conclusions: These results indicated that genetic variants in the TIRAP gene might be associated with
susceptibility to sepsis-associated ALI in Han Chinese population. However, the association needs to be replicated
in independent studies.
Background
Acute lung injury (ALI) and its more severe form, the
acute respiratory distress syndrome (ARDS), are syn-
dromes of acute respiratory failure that are characterized
by acute pulmonary edema and lung inflammation. ALI
remains an important cause of death in the intensive
care units (ICU) and few specific therapies are available
[1]. Although sepsis, pneumonia, aspiration, trauma,
pancreatitis and multiple transfusion are recognized as
the most common causes of ALI, only a small fraction
of patients with these risk factors develop ALI [2]. Clini-
cal and epidemiological studies have supported the
hypothesis that genetic factors might play a part in the
development and outcome of ALI [3-10]. Identification
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of genetic variants may provide new insight into the
molecular pathogenesis of ALI and lead to the develop-
ment of new diagnostic and therapeutic targets [6].
The pathogenetic basis of ALI is incompletely under-
stood. However, emerging evidence has suggested that
the severity and outcome of ALI depend significantly on
systemic inflammatory response [11]. TLRs recognize a
diverse array of pathogens and initiate intracellular sig-
naling via their Toll/interleukin-1 receptor domains,
leading to an inflammatory host response [12]. Accumu-
lating evidence has demonstrated that inappropriate
activation of TLRs signaling pathways plays an impor-
tant role in the pathogenesis of ALI [13]. The adaptor
protein Mal (TIR domain-containing adaptor protein,
TIRAP), encoded by the TIRAP gene, is essential for
MyD88-dependent signaling downstream of TLR2 and
TLR4. After stimulation of TLR2 or TLR4, Mal triggers
a signaling cascade, which culminates in the activation
of the nuclear factor-B (NF-B) and the subsequent
activation of pro-inflammatory genes [14]. Therefore, we
considered the TIRAP a robust candidate gene for ALI
susceptibility.
Two functional SNPs in the TIRAP gene have been
found association with inflammatory diseases suscept-
ibility [15-19]. Hawn and coworkers found that the T
allele of rs7932766 (C558T), related to lower levels of
plasma interlukin-6 (IL-6), was associated with increased
susceptibility to meningeal tuberculosis [17]. Recently,
another SNP rs8177374 (C/T), which causes a leucine
substitution at serine 180 of Mal (S180L), was reported
association with susceptibility to pneumococcal disease,
bacteremia, malaria, tuberculosis and septic shock
[15,16]. S180L leads to an amino acid substitution in
which Mal alters TLR2 and TLR4 signaling and thereby
protects against excessive or inappropriate inflammation
[15,16]. To our knowledge, no studies have addressed
the impact of TIRAP genetic variants on ALI risk.
Given the importance of exaggerated inflammatory
response in the pathogenesis of ALI, and the pivotal role
of TIRAP in this process, we hypothesized that genetic
variants in TIRAP might be associated with susceptibility
to ALI. Therefore, we performed a prospective study in a
Han Chinese sepsis-associated ALI sample set using tag
SNP approach to examine this hypothesis.
Methods
Study enrollment and design
The present study was reviewed and approved by the
Ethics Study Board of Zhongshan Hospital, Fudan Uni-
versity, Shanghai, China (No: 2006-23). Informed written
consent was obtained from all subjects or from their
legal surrogates before enrollment. Definitions of sepsis
and ALI/ARDS were in accordance with the American
College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference [20] and the Ameri-
can-European Consensus Conference statements
(AECC) (Additional file 1: Supplemental Table S1) [21].
All sepsis subjects enrolled had either severe sepsis or
septic shock. All patients were selected from the Emer-
gency and Respiratory ICUs at Zhongshan Hospital
(Shanghai, China), and were treated according to the
Surviving Sepsis Campaign guidelines [22]. Exclusion
criteria included age below 18 years, severe chronic
respiratory disease, severe chronic liver disease (defined
as a Child-Pugh score of > 10), using of high-dose
immunosuppressive therapy and AIDS patients. All sep-
sis patients were screened daily for ALI/ARDS develop-
ment and those who fulfilled the AECC criteria for ALI/
ARDS were considered as ALI cases, which included
ALI and ARDS patients; whereas those patients who did
not develop ALI/ARDS during hospital stay were con-
sidered as sepsis alone patients. Baseline characteristics,
source of infection, and Acute Physiology and Chronic
Health Evaluation (APACHE) II scores of all patients
were obtained during ICU stay. Sex- and age-matched
controls were selected from healthy blood donors. Ques-
tionnaires including smoking, chronic illness and the
history of ALI or sepsis were obtained from all control
subjects. Healthy controls were defined as individuals
without any recent acute illness, any chronic illness and
a history of ALI or sepsis. To reduce the potential con-
founding from ethnic backgrounds, we only enrolled
people with self-reported origin of central Han Chinese,
including indigenous people from Zhejiang Province,
Jiangsu Province, Anhui Province and Shanghai [23,24].
SNP selection and genotyping
Tag SNPs were selected based on the data of Han
Chinese in Beijing (CHB) from the HapMap project
phase II [25]. Three tag SNPs (rs595209, rs3802813 and
rs8177375) for the 11.85-kb region encompassing the
entire TIRAP gene were identified by Tagger within
Haploview using the following tagging criteria: pairwise
tagging of the HapMap CHB Population with r2 ≥ 0.8
and a minor allele frequency (MAF) ≥ 5%. Additionally,
two coding SNPs (rs8177374 predicting Ser180Leu, and
rs7932766 predicting Ala186Ala) were also genotyped in
this study as they have showed evidence of association
with other inflammatory diseases [15-19]. These were
not genotyped as part of the HapMap project.
Genomic DNA was extracted from whole blood using
FlexiGene DNA Kit (Qiagen Hilden, Germany) following
the manufacturer’s protocol. Genotyping was performed
by direct sequencing at the Chinese National Human
Genome Center in Shanghai, China. Using Primer 3
software, we designed two primers to completely incor-
porate the five SNPs. A 693 bp fragment harboring
rs595209 and rs3802813 was amplified using the
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following primers: forward, 5’-TGGTGAAACCC-
CGTCTCTAC-3’ and reverse, 5’-TGGCACAGCTCG-
GACACTAT-3’. Another 519 bp fragment harboring
rs7932766, rs8177374 and rs8177375 was amplified
using the following primers: forward, 5’-GCCAGG-
CACTGAGCAGTAGT-3’ and reverse, 5’-ATGTTCT-
GAGCCCTTCGTGT-3’. The PCR cycling conditions for
both fragments involved a denaturation step at 95°C for
5 min and then 35 cycles of 95°C for 30 s, 57°C for 40 s
and 72°C for 45 s, with a final elongation cycle of 72°C
for 8 min.
The sequencing reactions were performed using
Applied Biosystems BigDye (version 3.1) chemistry
(Applied Biosystem, Foster City, CA, USA), and the
sequences were resolved using an ABI 3730 Genetic
Analyzer. Analyses of the sequence traces were per-
formed using the Staden package and double scored by
a second operator [26]. A duplicate were added to each
96-well sample plate for quality assurance and quality
control validation of inter-plate discordance, and we
placed an extra 10 duplicates into our sample set in
order to test for experiment-wide discordance. The data
completion rate was 99%.
Statistical analysis
The demographic variables between different groups
were compared by c2 test for categorical variables and
by one-way ANOVA or Student’s t-test for continuous
variables. Genotype distributions were evaluated for
departures from Hardy-Weinberg equilibrium by the
Haploview v4.1 software [27]. The differences in allele
and genotype distributions between groups were exam-
ined for statistical significance with c2 test or with Fish-
er’s exact test when appropriate. P values for genotypic
distributions were calculated using the global genotype
test. Allele counts in cases and controls were used to
calculate the OR and the 95% CI. Multiple logistic
regression was used to evaluate if each SNP was inde-
pendently associated with ALI when adjusted for the
potential confounding effects of important clinical vari-
ables. When comparing ALI patients to sepsis alone
patients, age, gender, body mass index (BMI), history of
smoking, diabetes, liver cirrhosis and APACHE II score
were included in the multivariate models because of
their established association with ALI [28-30]. When
comparing ALI patients to healthy controls, age, gender,
BMI and history of smoking were included in the multi-
variate models. A two tailed P-value of < 0.05 was con-
sidered statistically significant, whereas a value of
corrected P < (0.05/number of tests), was considered
significant after Bonferroni correction. The linkage dise-
quilibrium (LD) between SNPs was calculated in terms
of r2 values by the Haploview v4.1 software [31]. Two-
locus haplotypes were estimated using EM algorithm by
Haploview v4.1. The haplotype-specific association was
analyzed by Haploview v4.1 and the omnibus test were
was analyzed by PLINK [32]. The case/control omnibus
test is an H-1 degree of freedom test, where H is the
number of different haplotypes. Each haplotype was
compared with all other haplotypes as the reference in
calculating the OR. The SNP-SNP interaction (epistasis)
was also investigated among the SNPs using PLINK
[32]. A P-value less than 0.05 was considered statistically
significant. The software used for statistical calculations
was the SPSS 15.0 (SPSS Inc., Chicago, IL, USA) unless
specified.
Results
Characteristics of the study population
From February 2006 to August 2009, a total of 278 sep-
sis-associated ALI (103 ALI, 175 ARDS) and 288 sepsis
alone patients were enrolled in this study. An additional
population of 298 ethnic-matched healthy blood donors
was recruited for comparison. The baseline characteris-
tics of the study population are shown in table 1. The
primary source of infection was the lungs, involving
87.1% of the combined sample of sepsis alone and ALI
patients. There was no significant difference in age, gen-
der, BMI, diabetes, liver cirrhosis and history of smoking
between ALI patients and sepsis alone patients (P >
0.05). Sepsis-associated ALI patients had average a
higher APACHE II scores and mortality ratio than sep-
sis alone patients (P < 0.001), although they were com-
parable in infection sites.
Associations of the TIRAP gene SNPs with ALI risk
Of the three tag SNPs, the MAFs of rs595209,
rs3802813 and rs8177375 in our sample were 32.1%,
16.3% and 11.6% respectively. The MAFs of the two
reported SNPs (rs7932766 and rs8177374) were lower
than 5% in our data (1.1% and 2.5%, respectively). The
genotype and allele frequencies of the five polymorph-
isms in all studied subjects are summarized in Addi-
tional file 1: Supplemental Table S2. The genotyping
success rates ranged from 98% to 99% and did not
diverge from Hardy-Weinberg equilibrium (P > 0.05)
(Additional file 1: Supplemental Table S2).
Single locus analysis showed two SNPs (rs595209 and
rs8177375) were associated with ALI risk, whereas other
three SNPs (rs3802813, rs7932766 and rs8177374)
showed no association (Table 2). The alleles of
rs595209A and rs8177375G occurred significantly more
frequently in the ALI group than in both the healthy
control group (OR = 1.47, P = 0.0027; OR = 1.97, P =
0.0001, respectively) and the sepsis alone group (OR =
1.44, P = 0.0041; OR = 1.82, P = 0.00079, respectively),
which remained significantly after Bonferroni correction.
Moreover, in multivariate analyses after adjustment for
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covariates, both SNPs were still significantly associated
with the development of ALI when compared with
healthy control group (ORadj = 1.43, Padj = 0.0036; ORadj
= 1.81, Padj = 0.00031, respectively) and sepsis alone
group (ORadj = 1.36, Padj = 0.0082; ORadj = 1.51, Padj =
0.0041, respectively). The genotypes frequencies of
rs595209 and rs8177375 in the ALI group were also sig-
nificantly different from that in the healthy control
group (P = 0.0034; P = 0.00047, respectively) and the
sepsis alone group (P = 0.0084; P = 0.0026, respectively),
the significance remained present in a multivariate ana-
lysis controlling for covariates and after Bonferroni cor-
rection (Table 2). However, the difference of the allele
and genotype frequencies of rs595209 and rs8177375
between subjects with sepsis alone and healthy controls
was not statistically significant (P > 0.05) (Additional file
1: Supplemental Table S3). No significant interaction
was found between rs595209 and rs8177375 (P > 0.05).
The low r2 value between the rs595209 and rs8177375
(r2 = 0.17) indicated the two signals were independent
not simply due to LD (Figure 1).
Associations of the TIRAP gene haplotypes with ALI risk
We next carried out haplotype analysis on the basis of
these two associated SNPs and found that a two-allele
model of risk provided the strongest predictor of risk,
which was highly significant (P = 0.00006 in ALI group
vs control group and P = 0.00003 in ALI group vs sepsis
alone group). The two SNPs (rs595209 C/A and
rs8177375 A/G) generated three common haplotypes
Table 1 Demographic and clinical characteristics of all subjects
Healthy controls Acute lung injury patients Sepsis alone patients P value
Number 298 278 (175 ARDS) 288 N.A
Age 65.3 ± 11.2 63.1 ± 12.1 64.8 ± 14.4 0.55
Male (%) 175 (58.7%) 166 (59.7%) 176 (61.1%) 0.84
BMI (kg.m-2) 21 ± 4 23 ± 8 22 ± 6 0.23
Diabetes 0% 43 (15.5%) 40 (13.9%) 0.60
Liver cirrhosis 0% 12 (4.3%) 9 (3.1%) 0.45
Smoker 125 (41.9%) 120 (43.2%) 117 (40.6%) 0.83
Sepsis Insult
Lung N.A 244 (87.8%) 249 (86.5%) 0.64
Abdomen N.A 15 (5.4%) 15 (5.2%) 0.92
UTI N.A 5 (1.8%) 7 (2.5%) 0.60
Bloodstream N.A 10 (3.6%) 11 (3.7%) 0.89
Other N.A 4 (1.4%) 6 (2.1%) 0.75
APACHE II N.A 19.5 ± 3.3 15.3 ± 2.6 < 0.001
Mortality (%) 0% 149 (46.4%) 96 (33.7%) < 0.001
ARDS, acute respiratory distress syndrome; N.A, not available; BMI, body mass index; UTI, urinary tract infection; APACHE, acute physiology and chronic health
evaluation.
Table 2 Association analysis of the five SNPs in TIRAP between different groups
SNP Reference Acute lung injury patients vs. Healthy controls Acute lung injury patients vs. Sepsis alone patients
allele OR ( 95% CI) Pa Pb OR (95%CI) Pa Pb
rs595209 A 1.47 (1.15-1.88) 0.0027 0.0034 1.44 (1.12-1.85) 0.0041 0.0084
1.43 (1.12-1.82)* 0.0036* 0.0041* 1.36 (1.07-2.02)* 0.0082* 0.0095*
rs3802813 A 1.13 (0.83-1.55) 0.44 0.34 1.03 (0.75-1.41) 0.85 0.61
1.10 (0.80-1.45)* 0.56* 0.48* 1.01 (0.61-1.24)* 0.91* 0.69*
rs8177374 T 1.43 (0.49-4.14) 0.51 0.59 1.67 (0.54-5.13) 0.85 0.41
1.28 (0.41-4.34)* 0.63* 0.75* 1.41 (0.51-4.93)* 0.92* 0.55*
rs7932766 T 0.49 (0.21-1.15) 0.095 0.091 0.58 (0.24-1.40) 0.22 0.28
0.56 (0.28-1.25)* 0.19* 0.23* 0.51 (0.20-1.34)* 0.28* 0.39*
rs8177375 G 1.97 (1.38-2.80) 0.0001 0.00047 1.82 (1.28-2.57) 0.00079 0.0026
1.81 (1.30-2.69)* 0.00031* 0.00098* 1.51 (1.15-3.04)* 0.0041* 0.0083*
SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval.
Pa, allelic P value; Pb, genotypic P value.
* The adjusted P-value and OR in multiple logistic regression after adjustment for clinical variables.
A P-value of < 0.01 (0.05/5) was considered statistically significant after Bonferroni correction. Rs595209 and rs8177375 remained significant after Bonferroni
correction.
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with frequency >5%: CA with frequency of 66.4%, AA
with frequency of 22.1% and AG with frequency of 9.8%.
A global test showed significant association with omnibus
p value of 0.015 in ALI group vs control group and 0.011
in ALI group vs sepsis alone group. In haplotype-specific
analysis, the frequency of haplotype AG (rs595209A,
rs8177375G) in the ALI samples was significantly higher
than that in the healthy control group (OR = 2.13, 95%
CI: 1.46-3.09, P = 0.00006) and the sepsis alone group
(OR = 2.24, 95% CI: 1.52-3.29, P = 0.00003), suggesting
its role as an ALI risk haplotype. After adjustment for
covariates, the haplotype AG still associated with
increased risk of ALI (Table 3). Another haplotype CA
(rs595209C, rs8177375A) appeared protective, as it was
found to be more frequent in both healthy control and
sepsis alone group than in the ALI group. Carriers of the
CA haplotype had a lower risk for ALI compared with
healthy control (OR = 0.69, 95% CI: 0.54-0.88, P =
0.0003) and sepsis alone group (OR = 0.71, 95% CI: 0.55-
0.91, P = 0.0006). The protective effect of haplotype CA
remained significant after adjustment for covariates
(Table 3). No association was found between haplotype
AA and ALI susceptibility. Similar to the results from
individual SNP analysis, the difference in the three
haplotypes frequencies between sepsis alone patients and
healthy controls was not statistically significant (P > 0.05)
(Additional file 1: Supplemental Table S4).
Discussion
TLRs and their signaling pathways play a central role in
the initiation of host immune response [12]. Previous
studies have described that excessive activation of host
immune response contributed to the overproduction of
proinflammatory cytokines and the development of ALI
or sepsis [13]. Recently, several variants in the TLR sig-
naling pathways genes have been reported to influence
the production of inflammatory cytokines and associate
with susceptibility to sepsis [15,17,33,34]. However, no
studies have addressed the impact of genetic variants in
TLR signaling pathways on susceptibility to or outcome
of ALI. To our knowledge, this was the first study to
investigate the association between the genetic variants
of TIRAP and the risk ALI. We found that the A allele
of rs595209 and the G allele of rs8177375 were signifi-
cantly associated with the increased risk of ALI. Consis-
tent with the single SNPs analysis, two haplotypes
constructed by rs595209 and rs8177375 were also asso-
ciated with the risk of ALI. These associations remained
significant after correction for multiple testing. However,
the distribution of TIPAP polymorphisms and haplo-
types were not significantly different between healthy
control and sepsis alone patients. Taken together, our
results provided strong evidence that TIPAP variants are
associated the development of sepsis-associated ALI.
TIRAP/Mal, a bridging adapter in the TLRs signaling
pathway, plays a significant role in the pathophysiology
of ALI and contributes to morbidity and mortality in
both animal models and humans [35]. TIRAP-deficient
mice was resistant to the toxic effects of lipopolysac-
charide, with defective induction of TNF-a, IL-6 and
IL-12, delayed activation of NF-B and MAP kinases.
Protein leak and neutrophil recruitment in the lung
were also abrogated in the TIRAP-deficient mice
[36,37]. Although rs8177374 and rs7932766 that influ-
ence inflammatory cytokine production were found
association with various inflammatory diseases, we did
not find any association between these two SNPs and
ALI susceptibility in the current study. Previous studies
showed that the minor allele frequencies of both
rs8177374 and rs7932766 were high in West-Eurasian
but rare in Asian populations [15,38]. The allele and
genotype frequencies of these two SNPs in our study
subjects were consistent with that in Asian populations
from the previous studies [15-17]. It was important to
note that, given the low minor allele frequencies, our
power to detect an association for these two polymorph-
isms was limited. Assuming the prevalence of 0.01 and
the OR of 1.5 and using a significance level of 0.05, our
Figure 1 Linkage disequilibrium plot of five single nucleotide
polymorphisms in TIRAP genotyped in the current study. We
constructed the plot with the Haploview program [27], and r2
(×100) values were depicted in the diamonds. The color code on
the plot follows the r2 scheme: r2 = 0, white; 0 < r2 < 1, shades of
grey; r2 = 1, black.
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study had only 11.9% and 11.8% power to detect asso-
ciation with rs8177374 (MAF of 1.0%) in 278 acute lung
injury patients and 288 sepsis alone patients vs. 298
control respectively, and had 25.0% and 24.7% power to
detect association with rs7932766 (MAF of 2.9%) in 278
acute lung injury patients and 288 sepsis alone patients
vs. 298 control respectively. A large-scale case-control
study in Han Chinese population should be performed
to evaluate the association between these two poly-
morphisms and ALI susceptibility.
When compared with the genotypes of other popula-
tions from HapMap, we found the rs8177375A allele
frequency in our healthy controls and those of Asian
descent (CHB), Europeans descent (CEU) and African
descent (YRI) from Hapmap does not vary significantly.
The minor rs595209 A allele associated with sepsis
related ALI has the frequency of 29.6% in the current
298 healthy controls, similar to the Hapmap CHB data
(34.3%). However, the A allele of rs595209 is the major
allele with a frequency of 93.2% in YRI and 83.2% in
CEU from Hapmap data. It remains to be determined
whether these differences between ethnic groups influ-
ence susceptibility to sepsis related ALI. Investigation in
other population is also expected to determine whether
the findings is Chinese population specific.
Rs595209 and rs8177375 were reported for the first time
to be associated with the susceptibility of ALI. These two
SNPs were both located in the non-coding region
of TIRAP. SNP rs595209 is located in the intron region of
TIRAP. Although rs595209 is at the neighboring region of
the nonsynonymous SNPs rs8177374 and rs7932766 in
the DNA sequence, these SNPs are not in high LD with
each other (Figure 1). SNP rs8177375 was located in the 3’
untranslated region (UTR) of the transcript NM_148910
and in the intron region of NM_001039661. It is well
known that 3’ UTRs are regulatory elements which can
control protein expression, primarily through effects on
mRNA stability and also through transcript translatability
[39]. Therefore, it is highly probable that rs8177375 alter
the structure of the 3’ UTRs, consequently influence the
expression of NM_148910. However, given that these
were tag SNPs, it is more likely that rs595209 and
rs8177375 are tagging other common or rare variants of
the TIRAP gene associated with ALI. Another possibility
is that the association might be due to LD with variants
from nearby genes. Exhaustive resequencing is required to
find or rule out the possibility an as-yet-unidentified causal
SNP in LD with rs595209 and rs8177375. And further
functional studies are needed to investigate whether the
variants have an effect on TIRAP mRNA stability and
translatability.
This study has a number of strengths. First, a sepsis
without ALI group was used for comparison to exclude
the possibility of a false association with sepsis. Second,
to minimize racial admixture, we focused on central
Han Chinese patients, which could be regarded as one
single homogenous population [23,24]. Third, to reduce
the heterogeneous etiologies for ALI, the present study
only included patients whose primary etiology for ALI
was sepsis. Of note, a major limitation of our study is
the lack of independent samples to validate the associa-
tions. Additionally, we did not resequence the gene and
instead used publicly available SNP databases. Thus,
some variants could have been missed due to incomple-
teness of these databases.
Conclusions
In conclusion, we reported for the first time that two tag
SNPs in the TIRAP gene contribute to increased risk of
sepsis-associated ALI in Han Chinese population. How-
ever, as this was the first study to analyze the genetic
variants in TIRAP and ALI risk, future studies are
needed to validate the associations in other populations
and exhaustively resequence of the TIRAP gene region.
Table 3 Association analysis of haplotypes in TIRAP between different groups
Haplotypes Healthy control Acute lung injury Sepsis alone Pa ORa (95% CI) Pb ORb (95% CI)
rs595209, rs8177375 (Frequency) (Frequency) (Frequency)
Global test 0.015 0.011
0.016* 0.014*
CA 0.678 0.602 0.686 0.0003 0.69 (0.54-0.88) 0.0006 0.71 (0.55-0.91)
0.00057* 0.75 (0.60-0.91)* 0.0009* 0.72 (0.54-0.93)*
AA 0.224 0.228 0.218 0.65 1.07 (0.81-1.41) 0.78 1.04 (0.79-1.38)
0.52* 1.12 (0.87-2.17)* 0.42* 1.21 (0.54-2.06)*
AG 0.076 0.157 0.080 0.00006 2.13 (1.46-3.09) 0.00003 2.24 (1.52-3.29)
0.0002* 1.78 (1.35-2.92)* 0.0004* 2.09 (1.41-3.01)*
OR, odds ratio; CI, confidence interval.
Pa and ORa , acute lung injury vs healthy control; Pb and ORb , acute lung injury vs sepsis alone.
* The adjusted P-value and OR in multiple logistic regression after adjustment for clinical variables.
A P-value of < 0.025 (0.05/2) was considered statistically significant after Bonferroni correction. Haplotypes CA and AG remained significant after Bonferroni
correction.
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Additional material
Additional file 1: Supplemental Table S1. The definitions of sepsis,
severe sepsis, septic shock and ALI/ARDS. The definitions for sepsis,
severe sepsis, septic shock and ALI/ARDS by the American College of
Chest Physicians/Society of Critical Care Medicine Consensus and the
American-European consensus conference statements. Supplemental
Table S2. Allele and genotype frequencies of the TIRAP gene SNPs in all
the subjects. Allele and genotype frequencies of rs595209, rs3802813,
rs8177375, rs8177374 and rs7932766 in the healthy controls, ALI patients
and sepsis alone patients. Supplemental Table S3. Association analysis of
the five SNPs in TIRAP between sepsis alone and healthy control groups.
Association analysis of rs595209, rs3802813, rs8177375, rs8177374 and
rs7932766 between healthy controls and sepsis alone patients.
Supplemental Table S4. Association analysis of haplotypes in TIRAP
between sepsis alone and healthy control groups. Association analysis of
three haplotypes (CA, AA and AG) between healthy controls and sepsis
alone patients.
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